Today’s guest: Joseph Kim | Senior Advisor in Translational Technology & Innovation at Eli Lilly
Greg and Joe talk about how technological advances have actually forced clinical trial sponsors to pay more attention to the patient’s experience, and why it is that MORE data doesn’t necessarily imply MEANINGFUL data.
Eli Lilly’s Elixir Factor Podcast: https://podcasts.apple.com/us/podcast/elixir-factor-podcast/id1459571012
Eli Lilly’s Clinical Trial Guide: https://www.lillytrialguide.com/en-US
Joe’s LinkedIn: https://www.linkedin.com/in/josephpennkim/
Joe’s Twitter: https://twitter.com/JoPeKim
Joe’s “Lilly Pad” profile: https://lillypad.lilly.com/?auth=44